HOME >> BIOLOGY >> NEWS
Learning to live with oxygen on early Earth

Washington, D.C. Scientists at the Carnegie Institution and Penn State University* have discovered evidence showing that microbes adapted to living with oxygen 2.72 billion years ago, at least 300 million years before the rise of oxygen in the atmosphere. The finding is the first concrete validation of a long-held hypothesis that oxygen was being produced and consumed by that time and that the transition to an oxygenated atmosphere was long term. The results are published in the on-line early edition of the Proceedings of the National Academy of Science, to appear the week of October 16th.

It is generally believed that before 2.4 billion years ago, Earth's atmosphere was essentially devoid of oxygen. Exactly when and how oxygen-producing photosynthesis evolved and began fueling the atmosphere with the gas that much of life depends on has been hotly debated for some time. Plants, algae, and cyanobacteria (blue-green algae) emit oxygen as a waste product of photosynthesis--the process by which sugar, essential for nutrition, is made from light, water, and carbon dioxide.

"Our evidence points to the likelihood that Earth was peppered with small 'oases' of shallow-water, oxygen-producing, photosynthetic microbes around 2.7 billion years ago," stated lead author Jennifer Eigenbrode of Carnegie's Geophysical Laboratory, who collected the data while pursuing her Ph.D. at Penn State. "Over time these oases must have expanded, eventually enriching the atmosphere with oxygen. Our data record this transition."

The researchers discovered changes in fossil isotopes of the life-essential element carbon in a 150 million-year section of rock that included shallow and deepwater sediments from the late Archean period (the Archean lasted from 3.8 to 2.5 billion years ago) in Hamersley Province in Western Australia. Isotopes are different forms of an element's atoms. The relative proportions of carbon and other isotopes in organic matter depend on c
'"/>

Contact: Jennifer Eigenbrode
j.eigenbrode@gl.ciw.edu
202-478-8981
Carnegie Institution
16-Oct-2006


Page: 1 2

Related biology news :

1. Learning to evolve: With a little help from my ancestors
2. Learning a second language -- Is it all in your head?
3. Protein pulling -- Learning how proteins fold by pulling them apart
4. Learning how to help migrating swans find forage
5. Learning during sleep?
6. Learning how nature splits water
7. Learning global solutions to local problems
8. Learning the lessons of the worlds oldest ecological experiment
9. Learning the language of DNA
10. SNM Lifelong Learning and Self-Assessment program modules approved by ABNM, ABR for CME credit
11. Learning to love bacteria: Stanford scientist highlights bugs benefits

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Learning live with oxygen early Earth

(Date:11/3/2014)... Research and Markets has announced the addition of a ... to their offering. This report describes ... started to play an important role in the practice of ... bone marrow transplants. Role of cells in drug discovery is ... of medical practice. Stem cells are discussed in ...
(Date:11/3/2014)... , Nov. 3, 2014  NeuroSigma ® ... -based life sciences company focused on commercialization of ... for the treatment of neurological and neuropsychiatric ... Industrial Property has issued a Notice of Allowance ... application is co-owned by NeuroSigma and the Regents ...
(Date:11/2/2014)... , James Dacey explores the ways in which physicists ... innovations from the lab into the commercial market. , ... companies as they move from prototype to product is ... physics-based inventions are usually far from market-ready when initially ... lot more complicated than had been originally thought. , ...
Breaking Biology News(10 mins):Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3The 'valley of death' facing physics start-ups 2
(Date:11/21/2014)... York, NY (PRWEB) November 20, 2014 ... is now available as an open access journal featuring ... with infrared fluorescent proteins to preserve photoresponsiveness in the ... Two-color fluorescent in situ hybridization using chromogenic substrates ... chips for DNA, RNA, and protein electrophoresis , ...
(Date:11/21/2014)... 21, 2014 2014 Deep Research ... is a professional and in-depth research report on ... information, like its definition, classification, application, and ... This report covers the international market analysis, including ... as the US, Europe, Asia, China, Japan etc. ...
(Date:11/21/2014)... Nov. 20, 2014 /CNW/ - Aequus Pharmaceuticals Inc. ... that it has closed a brokered private placement ... approximately C$3.7 million.  Cormark Securities Inc. and Clarus ... Brokered Offering for a syndicate of agents that ... Corp. (collectively the "Agents"). Concurrently with the Brokered ...
(Date:11/18/2014)... Nov. 18, 2014 Cord Blood Registry® (CBR®) ... the 10th Annual World Stem Cell Summit, the largest global ... 2014 World Stem Cell Summit will be held December 3-5 ... . The World Stem Cell ... lifesaving cures and therapies, convening the most prominent figures in ...
Breaking Biology Technology:BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3Cord Blood Registry Sponsors 2014 World Stem Cell Summit 2Cord Blood Registry Sponsors 2014 World Stem Cell Summit 3
Cached News: